The Wistar Institute
Wistar Scientists Identify New Therapeutic Target in Ovarian Cancer Subtype With Poor Prognosis
PHILADELPHIA — (Sept. 21, 2021) — Mutations in the ARID1A gene are present in more than 50% of ovarian clear cell carcinomas (OCCC), for which effective treatments are lacking. Scientists at The Wistar Institute discovered that loss of ARID1A functi…
Dr. Noam Auslander: New Faculty Addition Brings Artificial Intelligence Research to Wistar
Wistar welcomes Dr. Noam Auslander as an assistant professor in the Cancer Center’s Molecular & Cellular Oncogenesis Program. She applies artificial intelligence (AI) through high-throughput computer approaches to interpret the very large sets o…
Dr. Hildegund Ertl: Vaccine Thought Leader and Formidable Presence
Dr. Hildegund Ertl, Wistar immunologist and vaccine developer, has been featured in local and national media and sought after by journalists as a source of expert opinions. A well-spoken scientist, always available to help unravel the many questions…
Bringing Together Cutting Edge Technologies, Daniel Claiborne, Ph.D., Charts a Course for Solving Puzzles About HIV Infection
Mice differ from people in many ways. But over the last decade, scientists have succeeded in engineering mice that are more humanlike in their ability to be infected with HIV, making it possible to study the disease, and develop vaccines and therapi…
Cheyney University Students Kick Off Their Biomedical Research Journey at Wistar
Last February, Wistar welcomed the inaugural group of Cheyney University students enrolled in the biomedical research and training program co-developed in 2020 by the nation’s first biomedical research institute and the nation’s first historically b…
Motivated By the Hard Questions in Cancer Research, Noam Auslander, Ph.D., Forges New Paths in Computational Biology
Many people unwind in front of the television after a long day. But Noam Auslander, Ph.D., who joined The Wistar Institute Cancer Center in June as an assistant professor, often spends the evening glued to the screen of her MacBook Pro laptop instea…
Studying Immunology and Cancer, Nan Zhang, Ph.D., Delves Into Mysteries Of Ovarian Cancer Metastasis
Few biologists can say they saw a type of cells for the first time. Nan Zhang, Ph.D., who started at The Wistar Institute in September as an assistant professor, became one of those biologists when, during his postdoctoral research at Washington Uni…
Destined for Science, Amelia Escolano, Ph.D., Develops New Vaccination Strategies to Outsmart HIV-1, and Other Highly Mutating Pathogens
Scientists developed COVID-19 vaccines in record time — less than a year after the genome of the virus was sequenced, countries started authorizing use of multiple vaccines. But the virus is rapidly changing, and new variants have been emerging that…
Viruses and Cancer
Viruses impact human health in many ways and can be the underlying agents that cause cancer. The pandemic has reminded us how pervasive viruses are in human life. We know they can cause infection, making us very sick, but did you know that about 15…
Expanding the Caspar Wistar Fellows Program
The Caspar Wistar Fellowship is a model for recruiting the best and brightest junior scientists to Wistar where they can build scientific networks and advance their unique independent research programs. Two years ago philanthropists Doug and Peggy B…